Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Japanese Hepatitis Patients Reject Government Aid Plan
Link ID 1770
Title Japanese Hepatitis Patients Reject Government Aid Plan
Url http://www.medscape.com/viewarticle/567829?src=rss
Description Japanese patients infected with hepatitis C in a high-profile scandal over tainted blood, on Thursday rejected a government compensation proposal. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Dec 21, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Humana First-Quarter Profit Rises 13 Percent
  Health insurer Humana Inc said on Monday that first-quarter profit rose nearly 13 percent, beating dramatically reduced expectations, helped by its commercial plans for employers and a lower-than-expected tax rate. Reuters Health Information
Category:   Articles > Business of Medicine


2. FDA Device Clearances: Bone Marrow Biopsy System, Ceramic Spinal Implant, Mobile Bearing Knee Implan
  The FDA has granted 510(k) clearance for a bone marrow biopsy system (OnControl) and special 510(k) clearance for a ceramic spinal implant (Valeo VBR), and it has approved a premarket application for a mobile bearing knee implant (NexGen LPS-Flex Mobile Knee). Medscape Medical News
Category:   Articles > Business of Medicine


3. U.S. Diabetes Costs Top $174 Billion
  Study shows that diabetes costs in the United States have risen nearly one-third since 2002. WebMD Health News
Category:   Articles > Business of Medicine


4. APP Raising Heparin Prices Amid Higher Costs
  APP Pharmaceuticals Inc, the main supplier of the blood thinner heparin to the U.S. market in the wake of a contamination scandal, said on Thursday it was raising prices because of higher costs for raw materials, additional testing and labor. Reuters Health Information
Category:   Articles > Business of Medicine


5. Baxter Recalls All Remaining Heparin Vial Products
  Baxter International is now recalling from the market all remaining lots and doses of its heparin sodium multidose and single-dose vials for injection and its heparin lock flush solutions. Medscape Medical News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS